Personal information

Activities

Employment (3)

Medical University of Lublin: Lublin, PL

2016-10-04 to present (Department of Pneumonology, Oncology and Alergology)
Employment
Source: Self-asserted source
Anna Grenda

BIOMED-LUBLIN: Lublin, PL

2015 to 2016 (Quality Control Department)
Employment
Source: Self-asserted source
Anna Grenda

District Sanitary-Epidemiological Station in Radom: Radom, PL

2008 to 2009 (Department of Epidemiology)
Employment
Source: Self-asserted source
Anna Grenda

Education and qualifications (4)

Medical University of Lublin: Lublin, PL

2010-10-01 to 2015-11-15 | PhD (Department of Medical Genetics)
Education
Source: Self-asserted source
Anna Grenda

Medical University of Lublin: Lublin, PL

2012-10-01 to 2013-06-24 | Laboratory Diagnostician (Faculty of Pharmacy with Medical Analytics Division)
Education
Source: Self-asserted source
Anna Grenda

Jagiellonian University: Krakow, PL

2009-10-01 to 2010-06-22 | Molecular Biologist, Postgraduate Studies
Education
Source: Self-asserted source
Anna Grenda

University of Agriculture in Lublin: Lublin, PL

2002-10-01 to 2007-06-22 | Biotechnologist
Education
Source: Self-asserted source
Anna Grenda

Works (30)

Cancer trigger or remedy: two faces of the human microbiome

Applied Microbiology and Biotechnology
2021 | Journal article
Source: Self-asserted source
Anna Grenda

Impact of copy number variant and single nucleotide polymorphism of the programmed death‑ligand 1 gene, programmed death‑ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non‑small cell lung carcinoma

Oncology Letters
2021 | Journal article
Source: Self-asserted source
Anna Grenda

Tissue microRNA expression as a predictor of response to immunotherapy in NSCLC patients

Frontiers in Oncology
2021 | Journal article
Source: Self-asserted source
Anna Grenda

Effect of <i>TOP2A</i> and <i>ERCC1</i> gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients

Archives of Medical Science
2020 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 2)‎

HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery

BMC Gastroenterology
2020 | Journal article
Source: Self-asserted source
Anna Grenda

HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery

BMC Gastroenterology
2020 | Journal article
Source: Self-asserted source
Anna Grenda

Poszukiwanie przyczyn oporności na immunoterapię pembrolizumabem u chorej na gruczołowego raka płuca z ekspresją PD-L1 - mikrobiom jelitowy „pod lupą”. [Aut.] A. Grenda, E. Iwan, P. Krawczyk, et al. Oncol. Clin. Pract. 2020, vol. 16. DOI: 105603/OCP.2020.0031

Onkologia w Praktyce Klinicznej. Edukacja
2020 | Journal article
Source: Self-asserted source
Anna Grenda

Poszukiwanie przyczyn oporności na immunoterapię pembrolizumabem u chorej na gruczołowego raka płuca z ekspresją PD-L1 - mikrobiom jelitowy „pod lupą”. [Aut.] A. Grenda, E. Iwan, P. Krawczyk, et al. Oncol. Clin. Pract. 2020, vol. 16. DOI: 105603/OCP.2020.0031

Onkologia w Praktyce Klinicznej. Edukacja
2020 | Journal article
Source: Self-asserted source
Anna Grenda

Promoter polymorphisms of <i>TOP2A</i> and <i>ERCC1</i> genes as predictive factors for chemotherapy in non-small cell lung cancer patients

Cancer Medicine
2020 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 2)‎

Sekwencjonowania nowej generacji (NGS) w kwalifikacji do terapii ukierunkowanych molekularnie i immunoterapii u chorych na nowotwory

Niedrobnokomórkowy rak płuca : terapie ukierunkowane na inne niż EGFR cele molekularne
2020 | Book chapter
Source: Self-asserted source
Anna Grenda

Sekwencjonowania nowej generacji (NGS) w kwalifikacji do terapii ukierunkowanych molekularnie i immunoterapii u chorych na nowotwory

Niedrobnokomórkowy rak płuca : terapie ukierunkowane na inne niż EGFR cele molekularne
2020 | Book chapter
Source: Self-asserted source
Anna Grenda

Terapia kryzotynibem u chorego na raka gruczołowego płuca ze współistnieniem rearanżacji genów ALK, ROS1 i zapaleniem płuc różnicowanym z COVID-19 - opis przypadku

Niedrobnokomórkowy rak płuca : terapie ukierunkowane na inne niż EGFR cele molekularne
2020 | Book chapter
Source: Self-asserted source
Anna Grenda

Terapia kryzotynibem u chorego na raka gruczołowego płuca ze współistnieniem rearanżacji genów ALK, ROS1 i zapaleniem płuc różnicowanym z COVID-19 - opis przypadku

Niedrobnokomórkowy rak płuca : terapie ukierunkowane na inne niż EGFR cele molekularne
2020 | Book chapter
Source: Self-asserted source
Anna Grenda

The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression - focus on intestinal microbiome

Oncology in Clinical Practice
2020 | Journal article
Source: Self-asserted source
Anna Grenda

Toxicity of carlina oxide - a natural polyacetylene from the Carlina acaulis roots - in vitro and in vivo study

Toxins
2020 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 4)‎

Questions around mutation T1010I in MET gene: results of next generation sequencing in Polish patient with suspected hereditary adenoid cystic carcinoma

European Review for Medical and Pharmacological Sciences
2020-09 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 3)‎

The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression - focus on intestinal microbiome

Oncology in Clinical Practice
2020-07-17 | Journal article
Source: Self-asserted source
Anna Grenda

<i>PD-L1</i> gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients

Cancer genetics
2019 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 2)‎

Beyond PD-L1 markers for lung cancer immunotherapy

International Journal of Molecular Sciences
2019 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 2)‎

Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patients

European Review for Medical and Pharmacological Sciences
2019 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 2)‎

MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer

Oncology Letters
2019 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 2)‎

Discrepancies between ALK protein disruption and occurrence of <i>ALK</i> gene rearrangement in Polish NSCLC patients

Journal of Thoracic Disease
2018 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 3)‎

Epidermal growth factor receptor mutation status: does younger mean more frequently mutated?

Balkan Journal of Medical Genetics
2017 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 3)‎

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

Oncotarget
2017 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 4)‎

New dancing couple: PD-L1 and MicroRNA

Scandinavian Journal of Immunology
2017 | Journal article
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 4)‎

Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL—another piece in the puzzle

Annals of Hematology
2017-01 | Journal article
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Source: Self-asserted source
Anna Grenda
grade
Preferred source (of 5)‎

CIRCULATING microRNAs - A NEW CLASS OF DIAGNOSTIC AND PROGNOSTIC BIOMARKERS IN NEOPLASTIC DISEASES

Postepy Biologii Komorki
2014 | Journal article
WOSUID:

WOS:000209828900002

Contributors: Budzynski, Michal; Grenda, Anna; Filip, Agata A.
Source: Self-asserted source
Anna Grenda via ResearcherID

Cytogenetic and molecular determinants of aggressive form of chronic lymphocytic leukemia,Cytogenetyczne i molekularne uwarunkowania agresywnej postaci przewlekłej białaczki limfocytowej

Acta Haematologica Polonica
2014 | Journal article
EID:

2-s2.0-84898825175

Contributors: Grenda, A.; Budzyński, M.; Filip, A.A.
Source: Self-asserted source
Anna Grenda via Scopus - Elsevier
grade
Preferred source (of 2)‎

MicroRNA molecules as a significant constituent in gene regulation mechanisms related to cancer,Czasteczki mikroRNA jako istotny skladnik mechanizmów regulacji ekspresji genów zwiazanych z nowotworami

Nowotwory
2014 | Journal article
EID:

2-s2.0-84896753995

Contributors: Budzynski, M.; Grenda, A.; Filip, A.A.
Source: Self-asserted source
Anna Grenda via Scopus - Elsevier

Biogenesis of microRNAs and their role in the development and course of selected hematologic disorders,Biogeneza cza̧steczek mikroRNA oraz ich znaczenie w powstawaniu i przebiegu wybranych zaburzeń hematologicznych

Postepy Higieny i Medycyny Doswiadczalnej
2013 | Journal article
EID:

2-s2.0-84878638794

Contributors: Grenda, A.; Budzyński, M.; Filip, A.A.
Source: Self-asserted source
Anna Grenda via Scopus - Elsevier
grade
Preferred source (of 2)‎

Peer review (5 reviews for 5 publications/grants)

Review activity for Applied microbiology and biotechnology (1)
Review activity for Cancer cell international. (1)
Review activity for Cell communication and signaling. (1)
Review activity for Cellular & Molecular Biology Letters. (1)
Review activity for Clinical & translational oncology. (1)